Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 2”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT00423592
What this trial is testing

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06176118
What this trial is testing

Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT06664801
What this trial is testing

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT03492177
What this trial is testing

A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 63
Testing effectiveness (Phase 2)Study completedNCT03638908
What this trial is testing

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

Who this might be right for
Pulmonary Arterial Hypertension
University of Texas Southwestern Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Early research (Phase 1)WithdrawnNCT02684786
What this trial is testing

Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Artery Hypertension
Mayo Clinic
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Testing effectiveness (Phase 2)Ended earlyNCT00832507
What this trial is testing

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 162
Testing effectiveness (Phase 2)Study completedNCT01179334
What this trial is testing

Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.

Who this might be right for
Pulmonary Hypertension
Bayer 18
Very early researchStudy completedNCT03655704
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

Who this might be right for
Pulmonary Arterial Hypertension
Steeve Provencher 7
Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT02736149
What this trial is testing

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 51
Large-scale testing (Phase 3)Study completedNCT00810693
What this trial is testing

Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Bayer 445
Large-scale testing (Phase 3)Active Not RecruitingNCT04175600
What this trial is testing

Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Actelion 138
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Testing effectiveness (Phase 2)UnknownNCT04915300
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Laval University 72
Load More Results